PSC-BASED CELL THERAPIES

Sponsored By 

Concurrent Speaker(s)

• 

  Tamar Harel Adar, PhD

  Matricelf, Israel
• 

  Felicia Pagliuca, PhD

  Vertex Pharmaceuticals, USA

Presenting Author(s)

• 

  Yoshiki Furukawa, PhD, MD

  Hematology
  Juntendo University School of Medicine, Japan
• 

  Ian Hay

  Research and Development
  Factor Bioscience Inc., USA
• AP

  Anne Plant, PhD

  Biosystems and Biomaterials
  National Institute of Standards and Technology, United States
• 

  Edoardo Sozzi

  Experimental Medical Science
  Lund University, Sweden

Emerging embryonic and induced pluripotent stem cell-derived cell therapies for a range of indications will be showcased in this session.

Presentations:

• AUTOLOGOUS 3D ENGINEERED TISSUES FOR THERAPEUTIC APPLICATIONS
  

  Concurrent Speaker: Tamar Harel Adar, PhD – Matricelf
• CO-GRAFT OF DOPAMINE PROGENITORS AND SUPPORTING CELLS TO ENHANCE CELL-BASED THERAPY FOR PARKINSON´S DISEASE
  

  Presenting Author: Edoardo Sozzi – Lund University
• LARGE-SCALE LIVE-CELL QUANTITATIVE LABEL-FREE IMAGING OF INDIVIDUAL IPSC FOR MONITORING PLURIPOTENCY
  

  Presenting Author: Anne L. Plant, PhD – National Institute of Standards and Technology
• ENGINEERED IPSC-DERIVED MACROPHAGES EVADE HOST-VERSUS-GRAFT ALLOREACTIVITY AND ENHANCE T CELL CYTOTOXICITY TO TRIPLE NEGATIVE BREAST AND OVARIAN CANCER CELLS IN VITRO
  

  Presenting Author: Ian Hay – Factor Bioscience Inc.
• GENERATION OF CD4 SINGLE POSITIVE CELLS FROM IPSCS AND INVESTIGATION OF CD4/CD8 T CELL LINEAGE CHOICE
  

  Presenting Author: Yoshiki Furukawa, PhD, MD – Juntendo University School of Medicine
• STEM CELL-DERIVED, FULLY DIFFERENTIATED ISLET CELLS FOR TYPE 1 DIABETES
  

  Concurrent Speaker: Felicia Pagliuca, PhD – Vertex Pharmaceuticals